Search

Search Results
Results 18601 - 18610 of 18646 for stroke
  • DBL Glyceryl Trinitrate
    Drug - 27 Jun 2022
    Consumer Medicine Information (CMI) about DBL Glyceryl Trinitrate intended for persons living in Australia.
  • Ovaleap
    Drug - 23 May 2022
    Consumer Medicine Information (CMI) about Ovaleap intended for persons living in Australia.
  • Dapa-Tabs
    Drug - 11 May 2022
    Consumer Medicine Information (CMI) about Dapa-Tabs (indapamide hemihydrate) intended for persons living in Australia.
  • Eprex
    Drug - 9 May 2022
    Consumer Medicine Information (CMI) about Eprex intended for persons living in Australia.
  • Clopixol
    Drug - 28 Mar 2022
    Consumer Medicine Information (CMI) about Clopixol intended for persons living in Australia.
  • Zanidip
    Drug - 13 Mar 2022
    Consumer Medicine Information (CMI) about Zanidip intended for persons living in Australia.
  • Physiotens
    Drug - 17 Feb 2022
    Consumer Medicine Information (CMI) about Physiotens intended for persons living in Australia.
  • Moxonidine Viatris
    Drug - 17 Feb 2022
    Consumer Medicine Information (CMI) about Moxonidine Viatris intended for persons living in Australia.
  • Moxonidine GX
    Drug - 17 Feb 2022
    Consumer Medicine Information (CMI) about Moxonidine GX intended for persons living in Australia.
  • Teveten Plus
    Drug - 16 Feb 2022
    Consumer Medicine Information (CMI) about Teveten Plus intended for persons living in Australia.

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback